Patent ID: 7115619

Claim:
A compound selected from compounds of the following formula, and pharmaceutically acceptable salts and solvates thereof: wherein: each one of R A1 , R A2 , R A3 , and R A4 is independently —H or a ring substituent; each one of R B5 , R B6 , and R B7 is independently —H or a ring substituent; each one of R C9 , R C10 , R C11 , and R C12 is independently —H or a ring substituent; R N8 is independently a nitrogen substituent; R N13 is independently a nitrogen substituent; and, Q is independently an anion; wherein: said ring substituents are independently selected from: halo; hydroxy; ether; formyl; acyl; carboxy; ester; acyloxy; oxycarbonyloxy; amido; acylamido; tetrazolyl; amino; nitro; cyano; azido; sulfhydryl; thioether; sulfonamido; unsubstituted C 1-7 alkyl; C 1-7 haloalkyl; C 1-7 hydroxyalkyl; C 1-7 carboxyalkyl; C 1-7 acyloxyalkyl; C 1-7 oxycarbonylalkyl; C 1-7 oxycarbonyloxyalkyl; C 1-7 aminoalkyl; C 1-7 amidoalkyl; C 1-7 acylamidoalkyl; C 1-7 cyanoalkyl; and C 5-20 aryl-C 1-7 alkyl; and said nitrogen substituents are independently selected from: unsubstituted C 1-7 alkyl; C 1-7 haloalkyl; C 1-7 hydroxyalkyl; C 1-7 alkoxyalkyl; C 1-7 carboxyalkyl; C 1-7 aminoalkyl; C 5-20 aryl-C 1-7 alkyl; C 3-20 heterocyclyl; C 5-20 aryl; C 1-7 alkyl-C 5-20 aryl; and C 5-20 haloaryl; and wherein: each alkyl group is aliphatic, and is saturated or partially unsaturated; and each aryl group is a carboaryl group or a heteroaryl group; with the proviso that the compound is not: 8,13-diethyl-6-methyl-8H-quino[4,3,2-kl]acridinium iodide; or, 8,13-diethyl-3,6,11-trimethyl-8H-quino[4,3,2-kl]acridinium iodide.